FEBUSTO – 40
Effective Uric Acid Control for Better Joint Health
FEBUSTO-40 is a premium-quality Febuxostat 40 mg tablet from Citric Labs, formulated for the management of chronic hyperuricemia in patients with gout. Febuxostat works by inhibiting xanthine oxidase, the enzyme responsible for uric acid production, thereby helping reduce uric acid levels and preventing gout flare-ups when used under medical supervision. Febuxostat is indicated for specific patients with gout, particularly when allopurinol is not suitable or has not been effective.
Composition
- Febuxostat 40 mg
Key Benefits
- Helps reduce elevated uric acid levels.
- Supports long-term management of gout under medical supervision.
- Inhibits xanthine oxidase to reduce uric acid production.
- High-quality formulation manufactured under strict quality standards.
- Suitable for PCD Pharma Franchise and Third Party Manufacturing.
- Available with premium packaging and consistent supply.
Product Description
FEBUSTO-40 by Citric Labs contains Febuxostat 40 mg, a xanthine oxidase inhibitor used to help lower uric acid levels in patients with gout and hyperuricemia. Manufactured under stringent quality standards, it is an excellent choice for PCD Pharma Franchise and Third Party Pharma Manufacturing partners across India.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
